MarketDavid Broecker
Company Profile

David Broecker

David Andrew Broecker is an American life sciences executive. He was president and CEO of Alkermes from 2007 to 2009 and was appointed president and CEO of the Indiana Biosciences Research Institute in 2015. He left that position in 2017.

Education and career
Broecker graduated from Carmel High School, where he led their football team to an undefeated season and the 1978 state 3A championship, tying the Indiana High School Athletic Association record for most touchdown passes in a championship game. In 1985, Broecker joined Eli Lilly and Company, starting in the medical device and diagnostics division that later became Guidant. He was then involved in development of Ceclor, Prozac, and Zyprexa, overseeing manufacturing operations in Germany and Ireland. In 2001, he was appointed as chief operating officer of Alkermes, later serving as both president and CEO. In 2016, the IBRI secured $100 million in grants under his leadership. ==References==
tickerdossier.comtickerdossier.substack.com